Quality of life in people with diabetes: A systematic review of studies in Iran

被引：80
作者：
Kiadaliri A.A. [1 ,2 ,3 ,6 ]
Najafi B. [4 ]
Mirmalek-Sani M. [5 ]
机构：
[1] Division of Health Economics, Department of Clinical Sciences, Malmo University Hospital, Lund University, Malmo
[2] Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran
[3] Health Economics and Management, Institute of Economic Research, Lun University, Lund
[4] Mehregan Parto Research Institute, Tehran
[5] International Cooperation Affairs, Deputy of Social Welfare, Ministry of Cooperatives, Labour and Social Welfare, Tehran
[6] Lund University, Department of Clinical Sciences, Malmo Skane University Hospital, Malmo
来源：
Journal of Diabetes & Metabolic Disorders | / 12卷 / 1期
关键词：
Diabetes; HRQoL; Iran; Systematic review;
D O I：
10.1186/2251-6581-12-54
中图分类号：
学科分类号：
摘要：
Evaluation of health-related quality of life (HRQoL) among people with diabetes has been growing in Iran over the last decade. The main aim of the current study was to systematically review the characteristics of these studies and examine quality of their findings. Persian (SID, Magiran) and English (Pubmed, Medline, Web of Science, CINAHL, Scopus, PsycINFO and ERIC) databases were systematically searched using the search terms: " diabetes" AND " quality of life" AND " Iran" . The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. A total of 46 studies passed the inclusion criteria and were included in the review. The included studies were conducted in 20 out of 30 provinces of the country. Most studies investigated HRQoL among people with type 2 diabetes. The Short Form Health Survey (SF-36) and WHO quality of life instruments (WHOQOL) were the main instruments used in these studies. Studies showed that people with diabetes had lower HRQoL than people without diabetes. Better socioeconomic status and better control of cardiovascular risk factors were associated with better HRQoL among the patients with diabetes. In general, the predictors of HRQoL among Iranian patients were similar to their international counterparts implying that diabetes patients share many common features. The reviewed studies suffer from major methodological and reporting flaws which limit validity and generalizability of their findings. © 2013 Kiadaliri et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 62 条
  • [1] Tofighi, S., Ahmad Kiadaliri, A., Sadeghifar, J., Raadabadi, M., Mamikhani, J., Health-Related Quality of Life among Patients with Coronary Artery Disease: a Post-Treatment Follow-Up Study in Iran (2012) Cardiol Res Pract 2012, 2012, p. 973974
  • [2] Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030 (2010) Diabetes Res Clin Pract, 87 (1), pp. 4-14. , 19896746
  • [3] Seshasai, S.R., Kaptoge, S., Thompson, A., Di Angelantonio, E., Gao, P., Sarwar, N., Diabetes mellitus, fasting glucose, and risk of cause-specific death (2011) N Engl J Med, 364 (9), pp. 829-841
  • [4] Guzder, R.N., Gatling, W., Mullee, M.A., Byrne, C.D., Early mortality from the time of diagnosis of Type 2 diabetes: a 5-year prospective cohort study with a local age- and sex-matched comparison cohort (2007) Diabet Med, 24 (10), pp. 1164-1167. , 17672858
  • [5] Oliva, J., Fernández-Bolaños, A., Hidalgo, A., Health-related quality of life in diabetic people with different vascular risk (2012) BMC Public Health, 12, p. 812. , 3519628, 22994940
  • [6] Zhang, P., Brown, M.B., Bilik, D., Ackermann, R.T., Li, R., Herman, W.H., Health utility scores for people with type 2 diabetes in U.S. managed care health plans: results from Translating Research Into Action for Diabetes (TRIAD) (2012) Diabetes Care, 35 (11), pp. 2250-2256. , 3476906, 22837369
  • [7] Esteghamati, A., Gouya, M.M., Abbasi, M., Delavari, A., Alikhani, S., Alaedini, F., Prevalence of diabetes and impaired fasting glucose in the adult population of Iran, national survey of risk factors for non-communicable diseases of Iran (2008) Diabetes Care, 31 (1), pp. 96-98
  • [8] Esteghamati, A., Meysamie, A., Khalilzadeh, O., Rashidi, A., Haghazali, M., Asgari, F., Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia (2009) BMC Public Health, 9, p. 167. , 2697989, 19480675
  • [9] Esteghamati, A., Khalilzadeh, O., Anvari, M., Meysamie, A., Abbasi, M., Forouzanfar, M., The economic costs of diabetes: a population-based study in Tehran Iran (2009) Diabetologia, 52 (8), pp. 1520-1527. , 19475364
  • [10] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009) PloS Med, 6 (7), p. e1000097. , 2707599, 19621072
1234567